The table below shows RESMED INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$1.75B
$1.40B
$693.30M
$351.15M
$736.72M
$802.25M
Capital expenditure
$89.86M
$99.46M
$119.67M
$134.84M
$102.71M
$95.33M
Investing cash flow
-$200.04M
-$269.78M
-$1.16B
-$229.92M
-$158.46M
-$179.86M
Dividends paid
$310.88M
$282.32M
$258.28M
$245.34M
$226.71M
RMD operating cash flow (10-K history)
RESMED INC reported operating cash flow of $1.75B for fiscal year 2025. That is up 25.0% from $1.40B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $547.93M (FY 2016) to $1.75B. Figures come from the company's audited annual reports as filed with the SEC.
